Inselspital

Running trials

• Not yet recruiting

  Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)

  NCT07782112· Phase 3· Source

• Recruiting

  Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

  NCT07020065· Phase 2· Source

• Recruiting

  Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

  NCT06710210· Source

• Recruiting

  Training Medical Residents in the Use of the Venous Excess UltraSound (VExUS) Score for Bedside Volume Assessment.

  NCT07541768· Source

• Recruiting

  Neurofeedback-based Visual Restoration Therapy

  NCT07237412· Source

• Recruiting

  Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.

  NCT06776172· Source

• Recruiting

  Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  NCT06401980· Phase 2· Source

• Recruiting

  Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure

  NCT06207383· Source

• Active, not recruiting

  A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

  NCT06012435· Phase 3· Source

• Recruiting

  Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

  NCT05658497· Source

• Recruiting

  Moderate Alcohol Consumption and Heart Function in Patients With a Recent Myocardial Infarction

  NCT05920629· Source

• Recruiting

  Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure

  NCT05679206· Source

• Recruiting

  Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

  NCT05522660· Phase 3· Source

• Recruiting

  PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

  NCT04790253· Source

• Active, not recruiting

  Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  NCT05243797· Phase 3· Source

• Recruiting

  Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

  NCT04498767· Source

• Active, not recruiting

  A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

  NCT04449874· Phase 1· Source

• Active, not recruiting

  Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

  NCT04245514· Phase 2· Source

• Recruiting

  E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

  NCT03818503· Source

• Recruiting

  Comparison of Optical Coherence Tomography-derived Minimal Lumen Area, Invasive Fractional Flow Reserve and FFRCT

  NCT03820492· Source

• Active, not recruiting

  1st Line Durvalumab in PS 2 NSCLC Patients

  NCT03620669· Phase 2· Source

• Active, not recruiting

  Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

  NCT03540420· Phase 2· Source

• Active, not recruiting

  Clinical and Radiological Outcomes of Medacta Shoulder System

  NCT03547947· Source

• Active, not recruiting

  Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma

  NCT02984410· Source

• Active, not recruiting

  Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

  NCT02799706· Phase 3· Source

• Recruiting

  Swiss Primary Biliary Cholangitis Cohort Study

  NCT03146910· Source

• Active, not recruiting

  Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

  NCT02375204· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease3 recruiting
• Lung cancer3 recruiting
• Prostate cancer3 recruiting
• Heart failure2 recruiting
• Melanoma2 recruiting
• Atrial fibrillation1 recruiting
• Bladder cancer1 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Gastric and esophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• High blood pressure1 recruiting
• Kidney cancer1 recruiting
• Multiple sclerosis1 recruiting
• Pancreatic cancer1 recruiting
• Primary biliary cholangitis1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Sarcoma1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  ICG for Visualization of the Ureters in DIE

  NCT05206279· Source

• Completed

  SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

  NCT04480372· Phase 2· Source

• Completed

  Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

  NCT06830408· Source

• Terminated

  Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

  NCT03708003· Phase 2· Source

• Completed

  Atezolizumab Trial in Endometrial Cancer - AtTEnd

  NCT03603184· Phase 3· Source

• Completed

  Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

  NCT02360579· Phase 2· Source